Kisqali (Ribociclib) 600 mg Daily Dose - 63 Film-Coated Tablets

Kisqali (ribociclib) is a targeted cancer medication indicated for the treatment of certain types of hormone receptor-positive, HER2-negative advanced or metastatic breast cancer.

EGP 52,000

In Stock

Delivery to governorates within 3-4 working days

Easy returns within 14 days

Product Reviews

Overall Rating

0

Based on 0 reviews

You can add a rating once you purchase the product through the My Orders page

Customer Reviews

No reviews yet

html { touch-action: manipulation; } .fallback-nojs { display: flex; flex-direction: column; justify-content: center; align-items: center; text-align: center; } .fallback-nojs a { color: currentColor; } .fallback-closed { height: 40vh; } .fallback-heading { font-family: 'LoewMedium'; font-weight: 500; padding-bottom: 16px; font-size: xx-large; } .fallback-message { font-family: 'LoewMedium'; } @media only screen and (max-width: 768px) { .fallback-heading { font-size: x-large; } }